English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Three years have passed since the global outbreak of severe acute respiratory syndrome (SARS). During this time, major progress has been made in understanding the mechanisms of infection [1]. Three-dimensional structures have been determined for a number of non-structural and structural proteins of the virus and of related coronaviruses [2-5]. In the absence of a crystal structure for the viral RNA polymerase, the main proteinase remains the most suitable anti-coronaviral drug target [3,6-10]. Progress in designing and synthesizing specific inhibitors for this enzyme will be reported.

Structure-based chemotherapy of SARS – where do we stand, three years after the global outbreak?